Heba Shawky

11PUBLICATIONS
23CO-AUTHORS
NanometrologyMolecular targetsNeurogeneticsHaematological tumoursGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 11, 2026
Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole-curcumin nanocomplex through TLR2-FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer.

|Jun 21, 2026
Mechanistic evidence for PI3K/Akt-driven reactivation of Nrf2/HO-1 by dapagliflozin in acute cisplatin hepatotoxicity.

|Jun 26, 2025
Molecular Screening Reveals De Novo Loss-of-Function NR4A2 Variants in Saudi Children with Autism Spectrum Disorders: A Single-Center Study.

Najwa M Alharbi, Wejdan F Baaboud, Heba Shawky

|Nov 16, 2024
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals.

Reem El-Shenawy, Rehab I Moustafa, Naiera M Helmy

|Jul 24, 2024
Co-administration of Ceratonia siliqua extract nanoparticles promotes the oral bioavailability and neurotherapeutic efficacy of donepezil in a dementia model.

Sylvia E Shaker, Dalia B Fayed, Heba Shawky

|May 29, 2024
Portulaca oleracea L seed extracts counteract diabetic nephropathy through SDF-1/IL10/PPARγ-mediated tuning of keap1/Nrf2 and NF-κB transcription in Sprague Dawley rats.

Wessam M Aziz, Samia A Ahmed, Sylvia E Shaker

Pageof 2

Frequent Collaborators

4 joint publications

Ashraf A Tabll

4 joint publications

Reem M Elshenawy

4 joint publications

Naiera M Helmy

4 joint publications

Rehab I Moustafa